Bonaventure Equity
VC Fund
West Palm Beach, United States
Bonaventure Equity is a VC fund in West Palm Beach focused on Biotechnology and Sales. Bonaventure Equity operates as a cannabis venture capital firm, committed to funding the next generation of innovative cannabis companies delivering economic, societal, cultural and healthcare benefits through leading technologies, services and science.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Bonaventure Equity invests in
Stages Bonaventure Equity invests in
Countries Bonaventure Equity invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Greg McKee
|
|||
Ross O'Brien
|
|||
3 more contacts available
Investment Focus
Industry
- Biotechnology 3 (60%)
- Sales 1 (20%)
- Chemical 1 (20%)
- Consumer 1 (20%)
- Health Care 1 (20%)
Stage
- Series A 3 (60%)
- Seed 1 (20%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Greg McKee
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
|
Ross O'Brien
Founder & CEO
|
Founder & CEO | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Nalu Bio
|
Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700xless land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis. | $12M / Series A / Feb 28, 2023 | |
FloraWorks
|
FloraWorks is a hemp derived cannabinoid manufacturer and supplier. They provide technical biotech enterprises with discovering rare and novel cannabinoids for commercial and therapeutic applications and developing and patenting scaled manufacturing pathways. | $2.3M / Series A / Dec 15, 2022 | |
|
FloraWorks
|
FloraWorks is a hemp derived cannabinoid manufacturer and supplier. They provide technical biotech enterprises with discovering rare and novel cannabinoids for commercial and therapeutic applications and developing and patenting scaled manufacturing pathways. | $2.3M / Series A / Dec 15, 2022 | |
|
Nalu Bio
|
Nalu Bio is a biotech company developing CBD (and cannabinoids) through chemistry (not plants), for companies who want pure and safe ingredients that are better for the planet. Ranked as the #1 CBD producer on the “google for ingredients.” Like plant-based meats, Nalu Bio will fundamentally disrupt CBD production with chemistry. Nalu Bio uses 700xless land, 70x less water, and 14x less energy to produce its cannabinoids while ensuring best-in-class purity and quality (0% THC, no chemicals, no pesticides) without the high capital investment costs of hemp extraction and biosynthesis. | $1.5M / Seed / Jan 07, 2021 | |
LeafWorks
|
LeafWorks is an alternative biotech company, specializing in plant identification, research and development for the cannabis, hemp and herbal industries. | $1M / Series A / Feb 12, 2020 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Bonaventure Equity invest in?
Bonaventure Equity invests primarily in Biotechnology, Sales and Chemical startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bonaventure Equity?
Public channels for Bonaventure Equity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bonaventure Equity?
The team at Bonaventure Equity includes Greg McKee (Managing Partner) and Ross O'Brien (Founder & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
